1-2 of 2
Natalie Sacks
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B20: Immune vs. clinical response monitoring in patients with metastatic hormone-refractory prostate cancer receiving combined prostate GVAX and anti-CTLA4 immunotherapy

Free
Saskia J.A.M. Santegoets, Alfons J.M. van den Eertwegh, Anita G.M. Stam, Rik J. Scheper, Sinead M. Lougheed, Petra E.T. Scholten, Helen Gall, Karin Jooss, Natalie Sacks, Thomas C. Harding, Kristen Hege, Israel Lowy, Winald R. Gerritsen, Tanja D. de Gruijl
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): B20.
https://doi.org/10.1158/1078-0432.TCME10-B20
Published: 02 February 2016
View articletitled, Abstract B20: Immune vs. clinical response monitoring in patients with metastatic hormone-refractory prostate cancer receiving combined prostate GVAX and anti-CTLA4 immunotherapy
Journal Articles

Granulocyte Macrophage Colony-Stimulating Factor–Secreting Allogeneic Cellular Immunotherapy for Hormone-Refractory Prostate Cancer

Available to Purchase
Eric J. Small, Natalie Sacks, John Nemunaitis, Walter J. Urba, Eugene Dula, Arthur S. Centeno, William G. Nelson, Dale Ando, Catherine Howard, Flavia Borellini, Minh Nguyen, Kristen Hege, Jonathan W. Simons
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3883–3891.
https://doi.org/10.1158/1078-0432.CCR-06-2937
Published: 02 July 2007
View articletitled, Granulocyte Macrophage Colony-Stimulating Factor–Secreting Allogeneic Cellular Immunotherapy for Hormone-Refractory Prostate Cancer
Open the PDF for Granulocyte Macrophage Colony-Stimulating Factor–Secreting Allogeneic Cellular Immunotherapy for Hormone-Refractory Prostate Cancer in another window